Back to Agenda
Panel Detail

Breakfast Roundtable Discussions

Wednesday, July 12, 2017
8:00 AM - 9:00 AM
Great Room
Kick off Partnering for Cures with an opportunity to network with peers who share your goals and interests. These roundtables bring together meeting participants across disciplines and sectors to discuss specific topics in biomedical R&D. Table topics and hosts are listed below.

Biosimilars: Changing the Value Equation
  • Kate Strayer-Benton, Director of Strategy, Momenta Pharmaceuticals, Inc.

Conquering Cancer: Opportunities for Innovation
  • Michael Kaplan, President and CEO, Melanoma Research Alliance

Dealing with Data: Making sense of it and sharing it
  • Scott Sutherland, Director, KDUX Group, Data Sciences Platform, Broad Institute of MIT & Harvard

Facing the Challenges of Rare and Genetic Diseases
  • Ellen Salkeld, Senior Director of Research, Aplastic Anemia and MDS International Foundation

Healthy NIH & FDA for a Healthy America: Government support of biomedical innovation
  • Jonathan Woodson, Larz Anderson Professor of Management and Professor of Surgery, Boston University; Director, Boston University Institute for Health System Innovation and Policy

Medical Philanthropy
  • Cara Altimus, Associate Director, Center for Strategic Philanthropy, Milken Institute

Paradox of Plenty: How organizations can make the most of recent increases in volunteerism and donations
  • Susan Levine, Specialist Leader, Strategy, Deloitte Consulting
  • Kimberly Myers, Senior Manager, Deloitte Consulting

Patient Engagement: What's the ROI?
  • Zachary Hallinan, Project Manager, Clinical Trials Transformation Initiative

The Future of Clinical Trials
  • Stephen Yates, Head, External Resource Optimization & Innovation, UCB Biosciences, Inc.

Value-based contracting: Challenges and Opportunities
  • Michael Sherman, Senior Vice President and Chief Medical Officer, Harvard Pilgrim Health Care

Topics are subject to changes, additions and deletions prior to Partnering for Cures.